We are excited to announce the winners of the biocrates publishing awards. These awards were designed to recognize the outstanding scientists who are using biocrates technology to make discoveries in the world of metabolomics and beyond. As we celebrate the great scientific accomplishments of 2021, each winner will receive a small award this month.
The biocrates publishing award categories
We nominated scientist in five categories of awards:
— Highest-Impact Paper Award
— Most Cited Paper Award
— Most Prolific Publisher Award
— People’s Choice Award
— Editor’s Choice Award
Highest Impact Paper Award
The Highest-Impact Paper Award goes to Dr. Arash Haghikia for his work in the European Heart Journal entitled “Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism,” with an impact factor of 29,983. Click here to read more on this article or see our social media posts on Twitter and LinkedIn.
Most Cited Paper Award
With 197 citations, the Most Cited Paper Award goes to the first three co-authors of “Altered bile acid profile associates with cognitive impairment in Alzheimer’s disease-An emerging role for gut microbiome” in Alzheimers and Demintia, Dr. Siamak Mahmoudian Dehkordi, Dr. Kwangsik Nho, and Dr. Matthias Arnold. Click here to read the article or the posts on Twitter and LinkedIn.
Most Prolific Publisher Award
We recognize that each member of a research team has a major role in driving a project towards publication. Thus, for our next award, we aimed to recognize those beyond the first author who are using metabolomics to achieve scientific advancements. The most prolific publisher award of 2021 goes to Dr. Marc Gunter for his work publishing 10 papers using biocrates technology. Listed below are the citations for each, including links to read more.
1. Dossus L, Kouloura E, Biessy C, Viallon V, Siskos AP, Dimou N et al.
Prospective analysis of circulating metabolites and endometrial cancer risk.
Gynecologic Oncology 2021; 162(2):475–81.
2. Guida F, Tan VY, Corbin LJ, Smith-Byrne K, Alcala K, Langenberg C et al.
The blood metabolome of incident kidney cancer: A case-control study nested within the MetKid consortium. PLoS Med. 2021; 18(9): e1003786.
3. His M, Lajous M, Gómez-Flores-Ramos L, Monge A, Dossus L, Viallon V et al.
Biomarkers of mammographic density in premenopausal women.
Breast Cancer Res 2021; 23(1):75.
4. His M, Viallon V, Dossus L, Schmidt JA, Travis RC, Gunter MJ et al.
Lifestyle correlates of eight breast cancer-related metabolites: a cross-sectional study within the EPIC cohort. BMC Med 2021; 19(1):312.
5. Iguacel I, Schmidt JA, Perez-Cornago A, van Puyvelde H, Travis R, Stepien M et al.
Associations between dietary amino acid intakes and blood concentration levels.
Clin Nutr 2021; 40(6):3772–9.
6. Kliemann N, Viallon V, Murphy N, Beeken RJ, Rothwell JA, Rinaldi S et al.
Metabolic signatures of greater body size and their associations with risk of colorectal and endometrial cancers in the European Prospective Investigation into Cancer and Nutrition.
BMC Med 2021; 19(1):101.
7. Papadimitriou N, Gunter MJ, Murphy N, Gicquiau A, Achaintre D, Brezina S et al.
Circulating tryptophan metabolites and risk of colon cancer: Results from case-control and prospective cohort studies. Int J Cancer 2021; 149(9):1659–69.
8. Schmidt JA, Fensom GK, Rinaldi S, Scalbert A, Gunter MJ, Holmes MV et al.
NMR Metabolite Profiles in Male Meat-Eaters, Fish-Eaters, Vegetarians and Vegans, and Comparison with MS Metabolite Profiles. Metabolites 2021; 11(2):121.
9. van Roekel EH, Bours MJL, van Delden L, Breukink SO, Aquarius M, Keulen ETP et al.
Longitudinal associations of physical activity with plasma metabolites among colorectal cancer survivors up to 2 years after treatment. Sci Rep 2021;
10. Viallon V, His M, Rinaldi S, Breeur M, Gicquiau A, Hemon B et al.
A New Pipeline for the Normalization and Pooling of Metabolomics Data.
Metabolites 2021; 11(9).
Editor’s Choice Award
Additionally, for the Editor’s Choice Award, our knowledge experts selected one article from 2021 to highlight as a representation of a great work in metabolomics using our technology. This paper highlights the use of metabolomics in prognosis prediction related to women’s health. This award goes to Dr. Eiji Hishinuma for his work entitled “Wide-Targeted Metabolome Analysis Identifies Potential Biomarkers for Prognosis Prediction of Epithelial Ovarian Cancer” in Toxins.
People’s Choice Award
Finally, the last award is our People’s Choice Award. We believe that everyone’s voice matters and wanted to give everyone the chance to vote on their favorite biocrates metabolomics article of 2021 on LinkedIn and Twitter. The results were combined from both polls and this year the award goes to Dr. Emrin Horgusluoglu for her work on the publication entitled “Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer’s disease.”
Congratulations to everyone! We look forward to your further discoveries as we celebrate your current victories. If you would like to read more about targeted metabolomics and its applications, please go to our literature page.